All In Biotech

Drug Trial Radar · NCT00075725

Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

High Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)

Last checked: Nov 19, 2026Latest source record: Apr 27, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 3,154 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,154

Actual

Start

Dec 29, 2003

Primary completion

Dec 31, 2010

Study completion Mar 31, 2021

Sponsor

Lead sponsor
Children's Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Jan 13, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 1 year, up to 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized phase III trial is studying dexamethasone to see how well it works compared to prednisone during induction therapy. This trial is also studying methotrexate and leucovorin calcium to see how well they work compared to methotrexate alone during maintenance therapy in treating patients with newly diagnosed acute lymphoblastic leukemia (ALL). Drugs used in chemotherapy, such as dexamethasone, prednisone, methotrexate, and leucovorin calcium, work in different ways to stop cancer cells from dividing so they stop growing or die. Giving more than one drug may kill more cancer cells. It is not yet known which combination chemotherapy regimen is more effective in treating acute lymphoblastic leukemia.

Conditions

  • Acute Lymphoblastic Leukemia
  • Adult B Acute Lymphoblastic Leukemia
  • Childhood B Acute Lymphoblastic Leukemia

Interventions

  • CyclophosphamideDrug

    Given IV

  • CytarabineDrug

    Given IT, SC, or IV

  • Daunorubicin HydrochlorideDrug

    Given IV

  • DexamethasoneDrug

    Given PO or IV

  • Doxorubicin HydrochlorideDrug

    Given IV

  • Leucovorin CalciumDrug

    Given IV

  • MercaptopurineDrug

    Given PO

  • MethotrexateDrug

    Given IT or IV

  • PegaspargaseDrug

    Given IM

  • PrednisoneDrug

    Given PO or IV

  • Radiation TherapyRadiation

    Undergo radiation therapy

  • ThioguanineDrug

    Given PO

  • Vincristine SulfateDrug

    Given IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Comparison of the Increase in Cure Rate of High Risk ALL Without Causing More Serious Side Effects Between InterventionsTime frame: 5 years

Locations

234 sites in 5 countries. Site status is shown where the registry gives one.

  • Children's Hospital of Alabama

    Birmingham, Alabama

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama

  • USA Health Strada Patient Care Center

    Mobile, Alabama

  • Banner Children's at Desert

    Mesa, Arizona

  • Phoenix Childrens Hospital

    Phoenix, Arizona

  • Banner University Medical Center - Tucson

    Tucson, Arizona

  • Arkansas Children's Hospital

    Little Rock, Arkansas

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Kaiser Permanente Downey Medical Center

    Downey, California

  • City of Hope Comprehensive Cancer Center

    Duarte, California

  • Loma Linda University Medical Center

    Loma Linda, California

  • Miller Children's and Women's Hospital Long Beach

    Long Beach, California

  • Children's Hospital Los Angeles

    Los Angeles, California

  • Cedars Sinai Medical Center

    Los Angeles, California

  • Mattel Children's Hospital UCLA

    Los Angeles, California

  • UCLA / Jonsson Comprehensive Cancer Center

    Los Angeles, California

  • Valley Children's Hospital

    Madera, California

  • UCSF Benioff Children's Hospital Oakland

    Oakland, California

  • Kaiser Permanente-Oakland

    Oakland, California

  • Children's Hospital of Orange County

    Orange, California

  • Lucile Packard Children's Hospital Stanford University

    Palo Alto, California

  • Sutter Medical Center Sacramento

    Sacramento, California

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California

  • Rady Children's Hospital - San Diego

    San Diego, California

  • UCSF Medical Center-Parnassus

    San Francisco, California

  • Santa Barbara Cottage Hospital

    Santa Barbara, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Presbyterian - Saint Lukes Medical Center - Health One

    Denver, Colorado

  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center

    Denver, Colorado

  • University of Connecticut

    Farmington, Connecticut

  • Connecticut Children's Medical Center

    Hartford, Connecticut

  • Yale University

    New Haven, Connecticut

  • Alfred I duPont Hospital for Children

    Wilmington, Delaware

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • Broward Health Medical Center

    Fort Lauderdale, Florida

  • Lee Memorial Health System

    Fort Myers, Florida

  • Golisano Children's Hospital of Southwest Florida

    Fort Myers, Florida

  • University of Florida Health Science Center - Gainesville

    Gainesville, Florida

  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital

    Hollywood, Florida

Showing 40 of 234 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.